Cannabis Users Spend Less Time in Epilepsy Monitoring Units—But the Reasons Are Unclear
Epilepsy monitoring unit cannabis use was linked to a shorter length of stay compared to non-users. Cannabis users showed higher event capture rates but also increased psychiatric comorbidities. These findings highlight the complexity of cannabis use in…
Cannabidiol Cortical Effects: Clinical Trial Data
Cannabidiol cortical effects clinical trial data show that CBD alone does not directly reduce brain electrical activity like traditional seizure medications. The anti-seizure benefits of CBD appear to result mainly from interactions with other seizure…
Cannabidiol Cortical Excitability Clinical Trial
This cannabidiol cortical excitability clinical trial data shows CBD did not directly reduce brain electrical excitability at doses up to 700 mg in healthy adults. The findings suggest seizure-control benefits likely arise from interactions with other…
Exploring CBD’s Anticonvulsant Mechanisms in Seizure Disorders
CBD anticonvulsant mechanisms are key to understanding seizure disorder treatments in both veterinary and human medicine. Research on dogs with epilepsy offers translational insights for human care. This emerging field helps guide dosing and safety…
A Desperate North Texas Mom Turns to CBD to Stop Her Son’s Seizures
Pediatric epilepsy CBD treatment offers hope for children with refractory seizures. However, legal access to CBD remains complex across states, impacting families' care options. This article highlights the challenges and clinical perspectives on CBD use…
Medical Cannabis Evidence Map: Broad Promise, Variable Proof
The 2024 medical cannabis evidence map synthesizes 194 systematic reviews across 71 health outcomes, focusing on high-quality evidence. It highlights positive or potentially positive effects for pain, seizures, anxiety, and more. This map guides…
Cannabidiol & Cortical Excitability: Clinical Trial Results
A cannabidiol anti-epileptic properties clinical trial found no direct effect of CBD on cortical excitability in healthy males. The study suggests CBD's benefits in seizure disorders may depend on interactions with clobazam. These findings impact…
Cannabinoid Clinical Trials: CBD and Cortical Excitability Insights
This clinical trial investigates CBD antiseizure pharmacokinetic interaction and its effects on cortical excitability. Results indicate CBD alone does not alter cortical excitability in healthy men. The findings highlight the importance of drug…
Cannabinoids in Pediatric Medicine: Evidence-Based Review
Cannabinoid clinical trials pediatric research provides evolving evidence on safety and efficacy in children. This review highlights cautious clinical consideration where conventional treatments fall short. Ongoing studies continue to inform best…
Cannabidiol for Lennox-Gastaut: Cannabinoid Clinical Trials
Clinically meaningful reduction in drop seizures has been observed in Lennox-Gastaut syndrome patients treated with cannabidiol. Clinical trials show that even reductions below 50% can improve patient quality of life. Caregiver-reported outcomes align…